EU2P
FICF , EMEA , UCB Pharma (Belgium) , H. LUNDBECK A/S , SARD , ERASMUS MC , Bayer Pharma AG , KI , Eli Lilly and Company Limited , University of Verona , Orion Corporation (Finland) , Novo Nordisk , UH , NOVARTIS , AstraZeneca (Sweden) , Amgen , GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. , ANSM , UNIVERSITE DE BORDEAUX , Roche (Switzerland) , ...
Start a new DMP in Loading
FICF , EMEA , UCB Pharma (Belgium) , H. LUNDBECK A/S , SARD , ERASMUS MC , Bayer Pharma AG , KI , Eli Lilly and Company Limited , University of Verona , Orion Corporation (Finland) , Novo Nordisk , UH , NOVARTIS , AstraZeneca (Sweden) , Amgen , GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. , ANSM , UNIVERSITE DE BORDEAUX , Roche (Switzerland) , BII GMBH , Janssen (Belgium) , ALMIRALL , Utrecht University
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::8f33963e9c924c064e499e5cc86f4b05&type=result"></script>');
-->
</script> For further information contact us at helpdesk@openaire.eu